Abstract:As a result of thrombosis or intimal hyperplasia, synthetic artificial vascular grafts had a low success rate when they were used to replace small-diameter arteries (inner diameter < 6 mm). C-type natriuretic peptides (CNP) have anti-thrombotic effects, and can promote endothelial cell (EC) proliferation and in-hibit vascular smooth muscle cell (SMC) over-growth. In this study, poly(epsilon-caprolactone) (PCL) vascular grafts loaded with CNP (PCL-CNP) were constructed by electrospinning. The PCL-CNP grafts were able to continuously release CNP at least 25 days in vitro . The results of scanning electron microscopy (SEM) and mechanical testing showed that the loading of CNP did not change the microstructure and mechani-cal properties of the PCL grafts. In vitro blood compatibility analysis displayed that PCL-CNP grafts could inhibit thrombin activity and reduce platelet adhesion and activation. In vitro cell experiments demon-strated that PCL-CNP grafts activated ERK1/2 and Akt signaling in human umbilical vein endothelial cells (HUVECs), as well as increased cyclin D1 expression, enhanced proliferation and migration, and increased vascular endothelial growth factor (VEGF) secretion and nitric oxide (NO) production. The rabbit arteri-ovenous (AV)-shunt ex vitro indicated that CNP loading significantly improved the antithrombogenicity of PCL grafts. The assessment of vascular grafts in rat abdominal aorta implantation model displayed that PCL-CNP grafts promoted the regeneration of ECs and contractile SMCs, modulated macrophage polariza-tion toward M2 phenotype, and enhanced extracellular matrix remodeling. These findings confirmed for the first time that loading CNP is an effective approach to improve the hemocompatibility and vascular regeneration of synthetic vascular grafts.Statement of significanceSmall-diameter (< 6 mm) vascular grafts (SDVGs) have not been made clinically available due to their prevalence of thrombosis, limited endothelial regeneration and intimal hyperplasia. The incorporation of bioactive molecules into SDVGs serves as an effective solution to improve hemocompatibility and en-dothelialization. In this study, for the first time, we loaded C-type natriuretic peptides (CNP) into PCL grafts by electrospunning and confirmed the effectiveness of loading CNP on improving the hemocompat-ibility and vascular regeneration of artificial vascular grafts. Regenerative advantages included enhance-ment of endothelialization, modulation of macrophage polarization toward M2 phenotypes, and improved contractile smooth muscle cell regeneration. Our investigation brings attention to CNP as a valuable bioac-tive molecule for modifying cardiovascular biomaterial.(c) 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Biofunctionalized Electrospun PCL-PIBMD/SF Vascular Grafts with PEG and Cell-Adhesive Peptides for Endothelialization

Co-immobilization of ACH11 Antithrombotic Peptide and CAG Cell-Adhesive Peptide Onto Vascular Grafts for Improved Hemocompatibility and Endothelialization.

Functionalization of the Surface of Electrospun Poly(Epsilon-Caprolactone) Mats Using Zwitterionic Poly(Carboxybetaine Methacrylate) and Cell-Specific Peptide for Endothelial Progenitor Cells Capture

Functional Modification of Electrospun Poly(ε-caprolactone) Vascular Grafts with the Fusion Protein VEGF–HGFI Enhanced Vascular Regeneration

Improving Vascular Regeneration Performance of Electrospun Poly(ε-Caprolactone) Vascular Grafts via Synergistic Functionalization with VE-Cadherin/VEGF

Rapid Endothelialization and Controlled Smooth Muscle Regeneration by Electrospun Heparin-Loaded Polycaprolactone/gelatin Hybrid Vascular Grafts

Effect of Sustained Heparin Release from PCL/chitosan Hybrid Small-Diameter Vascular Grafts on Anti-Thrombogenic Property and Endothelialization.

Nanofibrous Vascular Scaffold Prepared from Miscible Polymer Blend with Heparin/stromal Cell-Derived Factor-1 Alpha for Enhancing Anticoagulation and Endothelialization

A small-diameter vascular graft immobilized peptides for capturing endothelial colony-forming cells

Polycaprolactone Vascular Graft with Epigallocatechin Gallate Embedded Sandwiched Layer-by-layer Functionalization for Enhanced Antithrombogenicity and Anti-Inflammation.

PREPARATION AND CHARACTERIZATION OF SMALL DIAMETER VASCULAR GRAFTS WITH NO GENERATION in situ AND SPECIFIC ADHESION OF ENDOTHELIAL CELLS

Development of small-diameter vascular grafts using PCL/PLA/gelatin/PVA/hyaluronic acid nanofibers containing VEGF/enoxaparin

Endothelialization and Patency of Rgd-Functionalized Vascular Grafts in A Rabbit Carotid Artery Model

Evaluation of mechanical properties and biocompatibility of three-layer PCL/PLLA small-diameter vascular graft with pore diameter gradient

Construction of tissue-engineered vascular grafts using electrospun pcl/phosphatidylcholine fibers

Electrospun Vein Grafts with High Cell Infiltration for Vascular Tissue Engineering

Expanded polytetrafluoroethylene/silk fibroin/salicin vascular graft fabrication for improved endothelialization and anticoagulation

The loading of C-type natriuretic peptides improved hemocompatibility and vascular regeneration of electrospun poly(-caprolactone) grafts

Electrospun polyhedral oligomeric silsequioxane-poly(carbonate-urea) urethane for fabrication of hemocompatible small-diameter vascular grafts with angiogenesis capacity

Construction and Performance of PLA-COL@PU-COL@PLA-PU-COL Electrospun Vascular Graft Modified with Chitosan/heparin

Plga/Sf Blend Scaffolds Modified with Plasmid Complexes for Enhancing Proliferation of Endothelial Cells